Riversedge Advisors’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$345K Buy
552
+32
+6% +$18.7K 0.04% 213
2026
Q2
$275K Buy
520
+93
+22% +$42.9K 0.04% 226
2026
Q1
$205K Sell
427
-131
-23% -$67.1K 0.03% 203
2025
Q4
$313K Buy
558
+132
+31% +$74.9K 0.05% 135
2025
Q3
$219K Buy
+426
New +$186K 0.04% 176

Other funds holding MEDP

Riversedge Advisors's MEDP Position: Q3 2026 in Review

Riversedge Advisors increased its Medpace (MEDP) stake by 6.2% in Q3 2026, buying an estimated $18.7K and bringing the position to 552 shares worth $345K. The position accounts for 0.04% of the portfolio, ranked #213.

Riversedge Advisors first reported a position in MEDP in Q3 2025 and has held it in 5 quarters since. 755 funds tracked by Wall St. Rank hold MEDP as of Q3 2026.

  • Riversedge Advisors held 552 shares of Medpace worth $345K as of Q3 2026.
  • Riversedge Advisors bought 32 Medpace shares in Q3 2026, an estimated $18.7K.
  • Medpace made up 0.04% of Riversedge Advisors's portfolio in Q3 2026, its #213 holding.
  • Riversedge Advisors first reported a position in Medpace in Q3 2025 and has held it in 5 quarters since.
  • 755 funds tracked by Wall St. Rank held Medpace as of Q3 2026.

Based on Riversedge Advisors's 13F filing for Q3 2026, filed 9 Oct 2026.